• High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug
  • High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug
  • High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug
  • High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug
  • High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug
  • High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug

High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug

Powder: Yes
Customized: Non-Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Adult
State: Solid
Purity: >98%
Samples:
US$ 10/gram 1 gram(Min.Order)
| Request Sample
Customization:

Contact Supplier

Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5

Basic Info.

Model NO.
TGY022019050803
Product Name
Phenylbutazone
Specificcation
99%
Grade
Pharmaceuticals Grade
Shelf Life
2 Years
Storage
Cool Dry Place
Shipping Time
Within 3-7 Working Days
CAS
50-33-9
Appearance
White Powder
Transport Package
Foil Bag, Box, Drum
Specification
99% min
Trademark
TGY
Origin
China
HS Code
300440906
Production Capacity
150kg/Month

Product Description


High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals DrugHigh Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug
Phenylbutazone Basic information
Product Name: Phenylbutazone
Synonyms: PHENYLBUTAZONE;1,2-Diphenyl-2,3-dioxo-4-N-butylpyrazoline;1,2-Diphenyl-3,5-dioxo-4-butylpyrazolidine;1,2-Diphenyl-4-butyl-3,5-dioxopyrazolidine;1,2-Diphenyl-4-butyl-3,5-pyrazolidinedione;3,5-dioxe-4buty-1,diphenyl-pyrazolidine;3,5-dioxo01,2-diphenyl-4-m-butyl-pyrazolidine;3,5-Dioxo-1,2-diphenyl-4-N-butyl-pyrazolidin
CAS: 50-33-9
MF: C19H20N2O2
MW: 308.37
EINECS: 200-029-0
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Heterocycles;Inhibitors;API;AZOLID
Mol File: 50-33-9.mol
mp  104-107 °C
storage temp.  -20°C Freezer
Water Solubility  <0.1 g/100 mL at 23.5 ºC
Merck  14,7277
BRN  290080
Stability: Stable. Incompatible with strong oxidizing agents, strong acids, strong bases.
CAS DataBase Reference 50-33-9(CAS DataBase Reference)
NIST Chemistry Reference Phenylbutazone(50-33-9)
EPA Substance Registry System 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-(50-33-9)


Phenylbutazone was originally made available for use in humans for the treatment of rheumatoid arthritis and gout in 1949. However, It is no longer approved, and therefore not marketed, for any human use in the United States. In the UK it is used to treat ankylosing spondylitis, but only when other therapies are unsuitable.

In horses

Phenylbutazone is the most commonly used NSAID for horses in the United States. It is used for the following purposes:

Analgesia: It is used for pain relief from infections and musculoskeletal disorders, including sprains, overuse injuries, tendinitis, arthralgias, arthritis, and laminitis. Like other NSAIDs, it acts directly on musculoskeletal tissue to control inflammation, thereby reducing secondary inflammatory damage, alleviating pain, and restoring range of motion. It does not cure musculoskeletal ailments or work well on colic pain.

Antipyresis: It is used for reduction of fevers. Its antipyretic qualities may mask other symptoms; therefore, it should not be administered for this purpose unless a veterinarian has concluded the horse would not be able to eat or drink without its use or that the fever might hinder the horse's recovery.

High Purity 99.5% Phenylbutazone 50-33-9 Pharmaceuticals Drug

Send your message to this supplier

*From:
*To:
avatar Miss Rebecca Lee
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Contact Supplier

Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5
Terms of Payment
LC, T/T, D/P, PayPal, Western Union, Small-amount payment
International Commercial Terms(Incoterms)
FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW, Others